A chitosan/acellular matrix-based neural graft carrying mesenchymal stem cells to promote peripheral nerve repair.

Stem Cell Res Ther · 2024 · PMC11687163 · PMID 39736729

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

At 8 and 12 W, the Chitosan + Acellular-MT + ADSC group showed a trend towards good sciatic nerve functional recovery, second only to the autograft group, which was significantly better than the chitosan and Chitosan + Acellular-MT groups, indicating that the Chitosan + Acellular-MT + ADSC group had a therapeutic level close to that of the autograft group (Fig. 4 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.